Moreover, the roles of the BLACAT1/miR-608/SOX12 axis in osteosarcoma (29), HOXD4-AS1/miR-608/FZD4 axis (30) in ovarian cancer, and lncRNA NORAD/miR-608/STAT3 (31) axis in melanoma indicate that miR-608 could be an ideal therapeutic target. This evidence concerns the gene FZD4 and ovarian carcinoma.